The Astrophysicist Who 'Hijacked' A Queen

What’s a scientist to do when an eclipse is best seen at sea? Commandeer an ocean liner On a dark night last March, the Queen Elizabeth II was sprinting across the Java Sea, tossing aside waves like an impatient leviathan. Nine mighty engines throbbed at full throttle, and the crew navigated through poorly charted waters with all the urgency and care of wartime maneuvers. But the ocean liner wasn’t rushing to deliver troops—as it had during the Falklands conflict--nor even

Written byJohn Carey
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

What’s a scientist to do when an eclipse is best seen at sea? Commandeer an ocean liner

On a dark night last March, the Queen Elizabeth II was sprinting across the Java Sea, tossing aside waves like an impatient leviathan. Nine mighty engines throbbed at full throttle, and the crew navigated through poorly charted waters with all the urgency and care of wartime maneuvers. But the ocean liner wasn’t rushing to deliver troops—as it had during the Falklands conflict--nor even to rescue a vessel in distress. Instead, it was pursuing science: This Queen had a date with an eclipse.

For Ken Brecher, anxiously pacing the liner’s deck, the dash across the sea was the final leg of a year-long odyssey. An astrophysicist at Boston University, Brecher was the man who had “hijacked” the Queen--all because he wanted to watch the sun disappear behind the moon. And when the night was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies